Literature DB >> 17717151

A common fold mediates vertebrate defense and bacterial attack.

Carlos J Rosado1, Ashley M Buckle, Ruby H P Law, Rebecca E Butcher, Wan-Ting Kan, Catherina H Bird, Kheng Ung, Kylie A Browne, Katherine Baran, Tanya A Bashtannyk-Puhalovich, Noel G Faux, Wilson Wong, Corrine J Porter, Robert N Pike, Andrew M Ellisdon, Mary C Pearce, Stephen P Bottomley, Jonas Emsley, A Ian Smith, Jamie Rossjohn, Elizabeth L Hartland, Ilia Voskoboinik, Joseph A Trapani, Phillip I Bird, Michelle A Dunstone, James C Whisstock.   

Abstract

Proteins containing membrane attack complex/perforin (MACPF) domains play important roles in vertebrate immunity, embryonic development, and neural-cell migration. In vertebrates, the ninth component of complement and perforin form oligomeric pores that lyse bacteria and kill virus-infected cells, respectively. However, the mechanism of MACPF function is unknown. We determined the crystal structure of a bacterial MACPF protein, Plu-MACPF from Photorhabdus luminescens, to 2.0 angstrom resolution. The MACPF domain reveals structural similarity with poreforming cholesterol-dependent cytolysins (CDCs) from Gram-positive bacteria. This suggests that lytic MACPF proteins may use a CDC-like mechanism to form pores and disrupt cell membranes. Sequence similarity between bacterial and vertebrate MACPF domains suggests that the fold of the CDCs, a family of proteins important for bacterial pathogenesis, is probably used by vertebrates for defense against infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717151     DOI: 10.1126/science.1144706

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  121 in total

Review 1.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Structural basis for membrane targeting by the MVB12-associated β-prism domain of the human ESCRT-I MVB12 subunit.

Authors:  Evzen Boura; James H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

3.  Perforin activity at membranes leads to invaginations and vesicle formation.

Authors:  Tilen Praper; Andreas F-P Sonnen; Ales Kladnik; Alberto O Andrighetti; Gabriella Viero; Keith J Morris; Emanuela Volpi; Lorenzo Lunelli; Mauro Dalla Serra; Christopher J Froelich; Robert J C Gilbert; Gregor Anderluh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

4.  Structure of complement C6 suggests a mechanism for initiation and unidirectional, sequential assembly of membrane attack complex (MAC).

Authors:  Alexander E Aleshin; Ingrid U Schraufstatter; Boguslaw Stec; Laurie A Bankston; Robert C Liddington; Richard G DiScipio
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

5.  Monomer-monomer interactions propagate structural transitions necessary for pore formation by the cholesterol-dependent cytolysins.

Authors:  Eileen M Hotze; Elizabeth Wilson-Kubalek; Allison J Farrand; Lori Bentsen; Michael W Parker; Arthur E Johnson; Rodney K Tweten
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

6.  Apicomplexan perforin-like proteins.

Authors:  Björn F C Kafsack; Vern B Carruthers
Journal:  Commun Integr Biol       Date:  2010-01

Review 7.  Membrane assembly of the cholesterol-dependent cytolysin pore complex.

Authors:  Eileen M Hotze; Rodney K Tweten
Journal:  Biochim Biophys Acta       Date:  2011-07-31

Review 8.  Membrane Repair: Mechanisms and Pathophysiology.

Authors:  Sandra T Cooper; Paul L McNeil
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

Review 9.  Pore-forming toxins: ancient, but never really out of fashion.

Authors:  Matteo Dal Peraro; F Gisou van der Goot
Journal:  Nat Rev Microbiol       Date:  2015-12-07       Impact factor: 60.633

10.  Dissecting the self-assembly kinetics of multimeric pore-forming toxins.

Authors:  A A Lee; M J Senior; M I Wallace; T E Woolley; I M Griffiths
Journal:  J R Soc Interface       Date:  2016-01       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.